Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (481)

Latest Posts

About This Stock More About This Stock
There Are Some Serious Deals In The Market Right Now
Video By: Jason Fieber
Saturday, June 11, 2022 2:40 PM EDT
Interested in buying high-quality dividend growth stocks on sale? Want to know my top five stocks for June 2022? Then you have to check out this video.
In this video: BK, LOW, UPS, GILD, QCOM
Watch
This Dirt-Cheap Stock Looks Attractive And Pays A Market-Smashing Yield
Video By: Jason Fieber
Monday, May 16, 2022 6:37 AM EDT
After all, if you got a health problem, you're going to do whatever is necessary to get treatment. Demand for these products is inelastic and growing. And that means a long runway for revenue, profit, and dividend growth.
In this video: GILD
Watch
Stocks Are Undervalued
Article By: Dividend Power
Sunday, May 15, 2022 7:57 AM EDT
The bear growled this past week as the S&P 500 Index skirted the (-20%) threshold. But Friday the markets bounced back, much to investors’ relief. The Index is still in a correction, although that may change next week if more bad news arrives.
In this article: BLK, EMR, LOW, MDT, MRK, GILD, INTC, MSFT, SBUX, TROW Also: QQQ
Read
Pummeled! These 5 Dividend Growth Stocks Are Down Big Time From Their 52 Week Highs
Video By: Jason Fieber
Monday, April 11, 2022 6:45 AM EDT
2022 has been nuts, right? After investing for more than a decade, I've never seen this kind of sustained daily volatility before. But, as always, I see short-term volatility as a long-term opportunity.
In this video: AOS, CMI, SHW, UGI, GILD
Watch
High Dividend 50: Gilead Sciences
Article By: SureDividend
Friday, March 18, 2022 5:38 PM EDT
Gilead is offering an all-time high dividend yield of 5.0% and is trading at a forward price-to-earnings ratio of 9.1. Unfortunately, there are good reasons behind these seemingly attractive features of the stock.
In this article: GILD
Read

Latest Tweets for $GILD

No tweets yet!

PARTNER HEADLINES

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments